key: cord-0322198-2spz2mkc authors: Lublin, Avishai; Katz, Chen; Gruzdev, Nady; Yadid, Itamar; Bloch, Itai; Farnoushi, Yigal; Simanov, Luba; Berkovitz, Asaf; Elyahu, Dalia; Pitcovskib, Jacob; Shahar, Ehud title: Protection against avian coronavirus conferred by oral vaccination with live bacteria secreting LTB-fused viral proteins date: 2021-10-04 journal: bioRxiv DOI: 10.1101/2021.10.04.462992 sha: f7f5dccaa9246e05ff8ff9f54d1b2cbfcfed5e48 doc_id: 322198 cord_uid: 2spz2mkc The devastating impact of infectious bronchitis (IB) triggered by the IB virus (IBV), on poultry farms is generally curbed by livestock vaccination with live attenuated or inactivated vaccines. Yet, this approach is challenged by continuously emerging variants and by time limitations of vaccine preparation techniques. This work describes the design and evaluation of an anti-IBV vaccine comprised of E. coli expressing and secreting viral spike 1 subunit (S1) and nucleocapsid N-terminus and C-terminus polypeptides fused to heat-labile enterotoxin B (LTB) (LS1, LNN, LNC, respectively). Following chicken oral vaccination, anti-IBV IgY levels and cellular-mediated immunity as well as protection against virulent IBV challenge, were evaluated 14 days following the booster dose. Oral vaccination induced IgY levels that exceeded those measured following vaccination with each component separately. Following exposure to inactivated IBV, splenocytes isolated from chicks orally vaccinated with LNN or LNC -expressing bacteria, showed a higher percentage of CD8+ cells as compared to splenocytes isolated from chicks vaccinated with wild type or LTB-secreting E. coli and to chicks subcutaneously vaccinated. Significant reduction in viral load and percent of shedders in the vaccinated chicks was evident starting 3 days following challenge with 107.5 EID50/ml virulent IBV. Taken together, orally delivered LTB-fused IBV polypeptide-expressing bacteria induced virus-specific IgY antibody production and was associated with significantly shorter viral shedding on challenge with a live IBV. The proposed vaccine design and delivery route promise an effective and rapidly adaptable means of protecting poultry farms from devastating IB outbreaks. Highlights Mucosal vaccination was shown particularly beneficial against respiratory viruses. An anti-IBV vaccine composed of three IBV polypeptides fused to LTB was designed. Vaccine composed of bacteria secreting polypeptides was orally delivered. Vaccine induced specific immune responses and shortened viral shedding duration. intramuscularly at a final volume of 0.5 ml (as a positive control). The experimental design included five groups as specified in Table 2 . Each bird in groups 1-6 was vaccinated intra-crop, 3 times, at 15, 36 and 45 days of age, 188 with 1 ml of a CAYE bacterial substrate as specified in Table 3 . The mixed bacterial 189 substrates delivered to groups 5 and 6 were prepared in a 1:1 or 1:1:1 ratio, respectively, 190 and a total of 1 ml of the mixture was administered. Chickens in group 7 were 191 subcutaneously vaccinated with 0.5 ml commercial inactivated IBV vaccine (Virasin 227, 192 Phibro, Israel). Following vaccination, chickens were inspected daily for clinical signs or Fisher's exact test were carried out to assess intergroup differences in the percentage of 247 birds that shed IBV. Antigen selection and fusion to carrier protein 251 The entire S1 segment and two separate segments of the nucleoprotein (NN: amino acids to that of the non-challenged negative control group. In all other groups, titres dropped 296 below 2 Log 10 EID 50 /ml, with high variability among the birds of the each group. Due to 297 this large variance within groups, statistical differences between groups were small. antigens S1 and N. The construct design was aided by use of 3D computer modelling 366 available for IBV proteins S and N. For the S1 protein sequence analysis, the cryo-electron 367 microscopy structure of infectious bronchitis coronavirus spike protein was used [40] . This structure is 96.5 identical to the S1 sequence from strain H120 and therefore served as the template for homology model of the S1 protein. The N protein had fragmented Table 1 The S1 segment is shown in green-surface representation. LTB is shown as a monomer in Early pathogenesis in chicks of infection with an 420 enterotropic strain of infectious bronchitis virus Studies on avian infectious bronchitis virus. 2. Incidence of the 422 virus in broiler and layer flocks, by isolation and serological methods Pathogenicity of four serotypes of avian infectious 425 bronchitis virus for the oviduct of young chickens of various ages Isolation of avian infectious bronchitis virus from 428 experimentally infected chickens Duration of experimental infectious bronchitis in chickens Coronavirus avian infectious bronchitis virus Avian pathology : journal of 434 the WVPA Recombinant live attenuated avian coronavirus vaccines with deletions in 437 the accessory genes 3ab and/or 5ab protect against infectious bronchitis in chickens Subunit Vaccines Against Emerging 440 Application of Viral Vectors for Vaccine Development with a The authors declare they have no conflict of interests.